YU1199A - Derivati benzosulfona - Google Patents

Derivati benzosulfona

Info

Publication number
YU1199A
YU1199A YU1199A YU1199A YU1199A YU 1199 A YU1199 A YU 1199A YU 1199 A YU1199 A YU 1199A YU 1199 A YU1199 A YU 1199A YU 1199 A YU1199 A YU 1199A
Authority
YU
Yugoslavia
Prior art keywords
hydrogen
amino
lower alkyl
nnr6r7
piridine
Prior art date
Application number
YU1199A
Other languages
English (en)
Inventor
Michael Bos
Walter Hunkeler
Claus Riemer
Original Assignee
F. Hoffmann-La Roche Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche Ag. filed Critical F. Hoffmann-La Roche Ag.
Publication of YU1199A publication Critical patent/YU1199A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
    • C07C317/36—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atoms of the amino groups bound to hydrogen atoms or to carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C07D213/71—Sulfur atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/38—One sulfur atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

Ovaj postupak se odnosi na nova jedinjenja opste formule u kojoj oznacavaju R1 vodonik, R2 vodonik, trifluorometil ili nizi alkil, R3 vodonik ili amino, ili R1 i R2 ili R3 i R2 uzeti zajedno ozncavaju -CH=CH-CH=CH-, Z pirimidin-4 -il, piridin-4-il, piridin-2-il ili fenil, R4, R5 svaki nezavisno jedan od drugog oznacavaju vodonik, nizi alkil, trifluorometil, halogen, nizi alkoksi, nitrilo, amino, nizi alkil-amino, di-nizi-alkilamino, piperazinil, morfolinil, pirolidinil, vinil, C3-C6- cikloalkil, C3-C6-cikloalkenil, terc-butilentinil, hidroksialkiletinil, naftil, tiofenil, ili fenil koji moze biti supstituisan halogenom, nizim-alkoksi-, nizim alkilom, trifluorometilom ili nitro-grupom, ili oznacava grupu -NH(CH2)nNR6R7, -N(CH3)(CH2)nNR6r7, -NH(CH2)n-morfolin-4-il ili -NH(CH2)n-OH, n 2-4 R6R7 svaki nezavisno jedan od drugog oznacavaju vodonik ili nizi alkil, i na njihove farmaceutski prihvatljive soli. Nadjeno je da jedinjenja formule I imaju selektivni afinitet prema 5HT-6 receptorima.
YU1199A 1998-01-16 1999-01-13 Derivati benzosulfona YU1199A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98100690 1998-01-16

Publications (1)

Publication Number Publication Date
YU1199A true YU1199A (sh) 2002-08-12

Family

ID=8231273

Family Applications (1)

Application Number Title Priority Date Filing Date
YU1199A YU1199A (sh) 1998-01-16 1999-01-13 Derivati benzosulfona

Country Status (34)

Country Link
US (1) US5990105A (sh)
EP (1) EP0930302B1 (sh)
JP (1) JP3249092B2 (sh)
KR (1) KR100319250B1 (sh)
CN (1) CN1148356C (sh)
AR (1) AR014313A1 (sh)
AT (1) ATE236136T1 (sh)
AU (1) AU757841B2 (sh)
BR (1) BR9900065A (sh)
CA (1) CA2258454A1 (sh)
CO (1) CO5090847A1 (sh)
CZ (1) CZ12099A3 (sh)
DE (1) DE69906397T2 (sh)
DK (1) DK0930302T3 (sh)
ES (1) ES2193607T3 (sh)
HK (1) HK1022310A1 (sh)
HR (1) HRP990011B1 (sh)
HU (1) HUP9900120A3 (sh)
ID (1) ID23234A (sh)
IL (1) IL128027A (sh)
MA (1) MA26599A1 (sh)
MY (1) MY121778A (sh)
NO (1) NO312065B1 (sh)
NZ (1) NZ333706A (sh)
PE (1) PE20000170A1 (sh)
PL (1) PL194735B1 (sh)
PT (1) PT930302E (sh)
RU (1) RU2201922C2 (sh)
SG (1) SG71898A1 (sh)
SI (1) SI0930302T1 (sh)
TR (1) TR199900090A2 (sh)
TW (1) TW553938B (sh)
YU (1) YU1199A (sh)
ZA (1) ZA99254B (sh)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7030109B2 (en) 1999-07-19 2006-04-18 Pharmacia & Upjohn Company 1,2,3,4,5,6-Hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position
MY122278A (en) 1999-07-19 2006-04-29 Upjohn Co 1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position
DE19956791A1 (de) * 1999-11-25 2001-05-31 Merck Patent Gmbh Neue Sulfonyloxazolamine
US7034029B2 (en) 2000-11-02 2006-04-25 Wyeth 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
EP1343756A2 (en) * 2000-11-02 2003-09-17 Wyeth 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
HUP0401235A2 (hu) 2001-08-10 2004-10-28 F. Hoffmann-La Roche Ag 5-HT6 receptor affinitással rendelkező arilszulfonil-származékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények
EP1434578A1 (en) * 2001-10-09 2004-07-07 PHARMACIA & UPJOHN COMPANY Arylsulphonyl-substituted tetrahydro- and hexahydro-carbazoles as 5-ht-6 receptor ligands
PL209872B1 (pl) * 2002-03-27 2011-10-31 Glaxo Group Ltd Pochodna chinolinowa, sposób jej wytwarzania i jej zastosowanie oraz zawierająca ją farmaceutyczna kompozycja
US6875771B2 (en) 2002-07-26 2005-04-05 Bristol-Myers Squibb Company Pyridopyrimidine derivatives as 5-HT6 antagonists
KR101052482B1 (ko) * 2002-11-21 2011-07-28 노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 포스포티딜이노시톨(ｐｉ) 3-키나제 억제제인 2,4,6-삼치환피리미딘 및 암의 치료에서 이들의 사용
GB0305575D0 (en) 2003-03-11 2003-04-16 Glaxo Group Ltd Novel compounds
GB0419192D0 (en) * 2004-08-27 2004-09-29 Merck Sharp & Dohme Therapeutic agents
SI1831159T1 (sl) * 2004-12-21 2010-04-30 Hoffmann La Roche Derivati tetralina in indana ter njune uporabe
JP2008540438A (ja) * 2005-05-04 2008-11-20 バーテックス ファーマシューティカルズ インコーポレイテッド イオンチャネルのモジュレーターとして有用なピリジン
JO2660B1 (en) 2006-01-20 2012-06-17 نوفارتيس ايه جي Pi-3 inhibitors and methods of use
EP2439201B1 (en) 2006-06-16 2013-08-07 H. Lundbeck A/S Compounds with combined sert, 5-ht3 and 5-ht1a activity
MX2009004947A (es) * 2006-11-09 2009-05-19 Hoffmann La Roche Arilsulfonil-pirrolidinas como inhibidores 5-hidroxitriptaminas6 (5-ht6).
EP2118087B1 (en) * 2007-02-06 2012-03-28 Novartis AG Pi 3-kinase inhibitors and methods of their use
CA2703157C (en) * 2007-10-26 2013-02-05 Suven Life Sciences Limited Amino arylsulfonamide compounds and their use as 5-ht6 ligands
WO2009128058A1 (en) 2008-04-18 2009-10-22 UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al Psycho-pharmaceuticals
UA100192C2 (en) 2008-11-11 2012-11-26 УАЙТ ЭлЭлСи 1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands
RU2443697C1 (ru) 2010-12-21 2012-02-27 Александр Васильевич Иващенко Замещенные метил-амины, антагонисты серотониновых 5-ht6 рецепторов, способы получения и применения
MX342326B (es) 2011-09-27 2016-09-26 Novartis Ag 3-pirimidin-4-il-oxazolidin-2-onas como inhibidoras de idh mutante.
UY34632A (es) 2012-02-24 2013-05-31 Novartis Ag Compuestos de oxazolidin- 2- ona y usos de los mismos
US9296733B2 (en) 2012-11-12 2016-03-29 Novartis Ag Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases
TWI686193B (zh) 2013-01-18 2020-03-01 美商卡爾迪奧克斯爾製藥公司 具有增進之治療指數的硝醯基予體
ES2665619T3 (es) 2013-03-14 2018-04-26 Novartis Ag 3-Pirimidin-4-il-oxazolidin-2-onas como inhibidores de IDH mutante
JP6454346B2 (ja) 2013-12-20 2019-01-16 サンシャイン・レイク・ファーマ・カンパニー・リミテッドＳｕｎｓｈｉｎｅ Ｌａｋｅ Ｐｈａｒｍａ Ｃｏ．，Ｌｔｄ． 芳香族複素環式化合物及び医薬におけるその応用
GB201514021D0 (en) 2015-08-07 2015-09-23 Arner Elias Set Jeno Novel Pyridines and their use in the treatment of cancer
JP2020507624A (ja) 2017-02-07 2020-03-12 オブリーク セラピューティクス アーベー スルフィニルピリジンおよび癌の治療におけるそれらの使用
EP3580209A1 (en) 2017-02-07 2019-12-18 Oblique Therapeutics AB Heterocyclylsulfonyl-substituted pyridines and their use in the treatment of cancer
MX2019009351A (es) 2017-02-07 2019-09-19 Oblique Therapeutics Ab Piridinas sustituidas con heteroarilsulfonilo y su uso en el tratamiento del cancer.
EP3580203A1 (en) 2017-02-07 2019-12-18 Oblique Therapeutics AB Hydrocarbylsulfonyl-substituted pyridines and their use in the treatment of cancer
HUE057970T2 (hu) 2018-03-08 2022-06-28 Incyte Corp Aminopirazindiol-vegyületek mint PI3K-Y inhibitorok
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55151560A (en) * 1979-05-14 1980-11-26 Ishihara Sangyo Kaisha Ltd Pyridylthioaniline compound
JPS60185764A (ja) * 1984-03-05 1985-09-21 Wako Pure Chem Ind Ltd ピリジン誘導体の新規な製造法
EP0513262B1 (de) * 1990-11-27 2000-04-05 MERCK PATENT GmbH 3,6-disubstituierte-2-fluoropyridine
GB9214120D0 (en) * 1991-07-25 1992-08-12 Ici Plc Therapeutic amides
JPH06127956A (ja) * 1992-10-16 1994-05-10 Copal Co Ltd ガラスレンズの成形装置
JP3907721B2 (ja) * 1995-08-23 2007-04-18 株式会社クラレ ２−アラルキルオキシピリジン類の製造法
JP3907722B2 (ja) * 1995-08-23 2007-04-18 株式会社クラレ ２−ヒドロキシピリジン類および／または２（１ｈ）−ピリドン類の製造法
EP0894791A4 (en) * 1996-03-29 2001-07-11 Ube Industries PYRIMIDINE COMPOUNDS, PROCESS FOR THE PRODUCTION THEREOF AND BACTERICIDES FOR AGRICULTURE AND HORTICULTURE
JP3814885B2 (ja) * 1996-09-03 2006-08-30 宇部興産株式会社 ２−シアノピリミジン誘導体、その製造法及び農園芸用の殺菌剤
JP2002507197A (ja) * 1997-05-30 2002-03-05 ビーエーエスエフ アクチェンゲゼルシャフト 置換チオピリジン
KR100396431B1 (ko) * 1998-01-26 2003-09-02 가부시키가이샤 구라레 2-술포닐피리딘 유도체 및 2-[((2-피리딜)메틸)티오]-1ｈ-벤즈이

Also Published As

Publication number Publication date
DE69906397T2 (de) 2004-02-19
MA26599A1 (fr) 2004-12-20
IL128027A (en) 2004-03-28
TR199900090A3 (tr) 1999-08-23
TW553938B (en) 2003-09-21
NZ333706A (en) 2000-08-25
US5990105A (en) 1999-11-23
AU757841B2 (en) 2003-03-06
CA2258454A1 (en) 1999-07-16
SI0930302T1 (en) 2003-10-31
ATE236136T1 (de) 2003-04-15
AU1211099A (en) 1999-08-05
EP0930302B1 (en) 2003-04-02
ID23234A (id) 2000-03-30
PL194735B1 (pl) 2007-06-29
ES2193607T3 (es) 2003-11-01
HRP990011A2 (en) 1999-10-31
ZA99254B (en) 1999-07-16
PE20000170A1 (es) 2000-03-29
HK1022310A1 (en) 2000-08-04
DK0930302T3 (da) 2003-07-21
PL330841A1 (en) 1999-07-19
MY121778A (en) 2006-02-28
EP0930302A3 (en) 1999-09-01
BR9900065A (pt) 2000-05-09
JP3249092B2 (ja) 2002-01-21
CN1148356C (zh) 2004-05-05
HUP9900120A2 (hu) 1999-11-29
EP0930302A2 (en) 1999-07-21
HRP990011B1 (en) 2004-12-31
CZ12099A3 (cs) 1999-08-11
SG71898A1 (en) 2000-04-18
KR19990067875A (ko) 1999-08-25
NO990187D0 (no) 1999-01-15
AR014313A1 (es) 2001-02-07
RU2201922C2 (ru) 2003-04-10
PT930302E (pt) 2003-07-31
NO990187L (no) 1999-07-19
HU9900120D0 (en) 1999-03-29
CN1231287A (zh) 1999-10-13
CO5090847A1 (es) 2001-10-30
DE69906397D1 (de) 2003-05-08
KR100319250B1 (ko) 2002-01-05
HUP9900120A3 (en) 2001-02-28
NO312065B1 (no) 2002-03-11
JP2000053635A (ja) 2000-02-22
IL128027A0 (en) 1999-11-30
TR199900090A2 (xx) 1999-08-23

Similar Documents

Publication Publication Date Title
YU1199A (sh) Derivati benzosulfona
TNSN00194A1 (en) Chemicals compounds
JO2321B1 (en) 4-phenyl-pyridine derivatives
YU8703A (sh) Derivati 4-fenil-piridina kao antagonisti receptora neurokinina-1
DK0663912T3 (da) Heterocykliske etherforbindelser til forstærkning af den kognitive funktion
RS20050789A (sr) Aril-supstituisana jedinjenja pirazol-amida pogodna za primenu kao inhibitori kinaze
DE69229674T2 (de) 5-ht4 rezeptor antagonisten
TW328089B (en) New azolidinediones as antihyperglycemic agents
ZA88309B (en) 3(2h)pyridazinone,process for its preparation and antagonistic agent against srs-a containing it
IL107961A0 (en) Phenoxy- and phenoxyalkyl-piperidines and pharmaceutical compositions containing them
AP9901578A0 (en) Sulfonylbenzene compounds as anti-inflammatory/analgesic agents.
TW429255B (en) Pyrazine compounds having treatment of central nervous system diseases and disorders
GB0216621D0 (en) Imaging compounds
YU64901A (sh) Derivati bifenila
DK1049672T3 (da) Azetidincarboxamid-derivater til behandling af CNS-lidelser
BG106152A (en) 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
DK1049670T3 (da) Azetidincarboxamidderivater til behandling af CNS-lidelser
ES2180201T3 (es) Derivados de azetidinona para el tratamiento de infecciones por hcmv.
ES2103675A1 (es) Nuevas piperidinas sustituidas.
GB9801501D0 (en) Chemical compounds - II
WO1992003412A3 (en) Benzamide derivatives
GR3006582T3 (sh)
ES2115303T3 (es) Uso de compuestos de 5-tia-1,4-diazabiciclo(4.2.0)octan-3,8-dioxo en terapia antitumoral.
NZ337271A (en) 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one derivatives and their use as dopamine autoreceptor (D2) agonists
ES8400106A1 (es) Procedimiento para la preparacion de derivados de tiosulfa- moiloxiacetamida